GSA Capital Partners’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $279K | Buy |
80,562
+28,083
| +54% | +$97.3K | 0.02% | 1304 |
|
|
2025
Q1 | $137K | Sell |
52,479
-77,469
| -60% | -$202K | 0.01% | 1468 |
|
|
2024
Q4 | $535K | Buy |
129,948
+114,541
| +743% | +$472K | 0.04% | 841 |
|
|
2024
Q3 | $109K | Sell |
15,407
-82,997
| -84% | -$587K | 0.01% | 1480 |
|
|
2024
Q2 | $642K | Buy |
98,404
+70,983
| +259% | +$463K | 0.04% | 802 |
|
|
2024
Q1 | $228K | Buy |
27,421
+5,499
| +25% | +$45.7K | 0.02% | 1347 |
|
|
2023
Q4 | $241K | Sell |
21,922
-90,179
| -80% | -$991K | 0.02% | 1229 |
|
|
2023
Q3 | $943K | Buy |
112,101
+52,712
| +89% | +$443K | 0.08% | 432 |
|
|
2023
Q2 | $746K | Buy |
+59,389
| New | +$746K | 0.07% | 482 |
|
|
2022
Q3 | – | Sell |
-178,593
| Closed | -$2.99M | – | 1813 |
|
|
2022
Q2 | $2.99M | Buy |
+178,593
| New | +$2.99M | 0.45% | 2 |
|